News headlines about Synopsys (NASDAQ:SNPS) have trended positive recently, according to Accern. The research group identifies negative and positive media coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Synopsys earned a media sentiment score of 0.26 on Accern’s scale. Accern also assigned news stories about the semiconductor company an impact score of 47.4962297999011 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

These are some of the news stories that may have effected Accern’s rankings:

Synopsys (NASDAQ:SNPS) traded up $1.12 during trading hours on Wednesday, hitting $86.62. The company had a trading volume of 1,292,451 shares, compared to its average volume of 990,956. Synopsys has a 12-month low of $65.56 and a 12-month high of $94.80. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.04 and a current ratio of 1.04. The firm has a market capitalization of $12,689.74, a PE ratio of 101.91, a PEG ratio of 3.80 and a beta of 1.04.

Synopsys (NASDAQ:SNPS) last posted its quarterly earnings results on Wednesday, November 29th. The semiconductor company reported $0.69 EPS for the quarter, beating the consensus estimate of $0.57 by $0.12. Synopsys had a return on equity of 5.78% and a net margin of 5.01%. The firm had revenue of $696.60 million during the quarter, compared to analysts’ expectations of $650.72 million. During the same quarter last year, the firm earned $0.77 earnings per share. The business’s revenue for the quarter was up 9.9% on a year-over-year basis. sell-side analysts forecast that Synopsys will post 2.24 EPS for the current year.

A number of brokerages have commented on SNPS. BidaskClub raised Synopsys from a “hold” rating to a “buy” rating in a report on Tuesday, January 23rd. Needham & Company LLC increased their target price on Synopsys from $83.00 to $100.00 and gave the company a “buy” rating in a report on Friday, December 1st. TheStreet cut Synopsys from an “a” rating to a “c+” rating in a report on Wednesday, November 29th. Zacks Investment Research cut Synopsys from a “hold” rating to a “strong sell” rating in a report on Monday, December 4th. Finally, JPMorgan Chase & Co. cut Synopsys from a “neutral” rating to an “underweight” rating and set a $87.00 target price for the company. in a report on Tuesday, December 12th. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and seven have assigned a buy rating to the stock. Synopsys has a consensus rating of “Hold” and an average target price of $96.89.

In related news, CEO Chi-Foon Chan sold 3,750 shares of the stock in a transaction that occurred on Friday, December 1st. The stock was sold at an average price of $89.78, for a total value of $336,675.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Steven Walske sold 4,545 shares of the stock in a transaction that occurred on Wednesday, January 17th. The shares were sold at an average price of $90.12, for a total value of $409,595.40. Following the completion of the sale, the director now directly owns 14,988 shares of the company’s stock, valued at approximately $1,350,718.56. The disclosure for this sale can be found here. In the last ninety days, insiders sold 65,442 shares of company stock valued at $5,779,693. Insiders own 1.82% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This story was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright legislation. The original version of this story can be viewed at https://www.thecerbatgem.com/2018/02/14/synopsys-snps-earns-coverage-optimism-score-of-0-26.html.

About Synopsys

Synopsys, Inc provides software, intellectual property (IP) and services. The Company supplies the electronic design automation (EDA) software that engineers use to design and test integrated circuits, also known as chips. It also offers IP products, which are pre-designed circuits that engineers use as components of larger chip designs rather than designing those circuits themselves.

Insider Buying and Selling by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.